Black Diamond Therapeutics (BDTX) EBITDA margin US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EBITDA margin, % | ? | 28.9% | ||||||
| Changes by years, y/y, % | ||||||||
Black Diamond Therapeutics. EBITDA margin, %
Black Diamond Therapeutics. EBITDA margin, changes, pp
Black Diamond Therapeutics (BDTX) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2024Q1 | FY2024Q2 | FY2024Q3 | FY2024Q4 | FY2025Q1 | LTM ? | |||
| EBITDA margin, % | ? | 78.0% | ||||||
| Changes by years, y/y, % | ||||||||
| Changes by quarters, q/q, % | ||||||||